SCHEMBL20942802

SCHEMBL20942802

CC[Si]1(OC(C)=O)CCCC1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20942790 0.98 ALDH1A1 (0.32) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL20942808 0.95 ALDH1A1 (0.33) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL20942811 0.80 ALDH1A1 (0.31) ALDH1A1
SCHEMBL20942793 0.78 FFAR3 (0.31) ALDH1A1
SCHEMBL20942812 0.76 ALDH1A1 (0.31) ALDH1A1
SCHEMBL20769869 0.71 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL8854366 0.70 ALDH1A1 (0.33) ALDH1A1HSD17B10TSHR
SCHEMBL20942803 0.69 HSD17B10 (0.32) ALDH1A1HSD17B10TSHR
SCHEMBL22632354 0.69 HSD17B10 (0.32) ALDH1A1HSD17B10TSHR
SCHEMBL20942791 0.67 HSD17B10 (0.31) ALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12533709-B2 Silacyclic compounds and methods for depositing silicon-containing films using same VERSUM MATERIALS US, LLC (US) 2026-01-27 US claimed
US-20210339280-A1 SILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING SILICON-CONTAINING FILMS USING SAME VERSUM MATERIALS US, LLC (US) 2021-11-04 US claimed
CN-109722648-B Silicon heterocyclic compound and method for depositing silicon-containing film using the same 弗萨姆材料美国有限责任公司 2021-06-25 CN claimed
EP-3476971-B1 SILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING SILICON-CONTAINING FILMS USING SAME VERSUM MAT US LLC (US) 2020-06-17 EP claimed
US-20190134663-A1 Silacyclic Compounds and Methods for Depositing Silicon-Containing Films Using Same VERSUM MATERIALS US, LLC (US) 2019-05-09 US claimed
EP-3476971-A2 SILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING SILICON-CONTAINING FILMS USING SAME Versum Materials US, LLC (US) 2019-05-01 EP claimed
EP-3476971-B1 SILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING SILICON-CONTAINING FILMS USING SAME VERSUM MAT US LLC (US) 2020-06-17 EP disclosed
EP-3476971-A2 SILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING SILICON-CONTAINING FILMS USING SAME Versum Materials US, LLC (US) 2019-05-01 EP disclosed
EP-3476971-A2 SILACYCLIC COMPOUNDS AND METHODS FOR DEPOSITING SILICON-CONTAINING FILMS USING SAME Versum Materials US, LLC (US) 2019-05-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12533709-B2 Silacyclic compounds and methods for depositing silicon-containing films using same OR10J3, SIK1, SIK2 ALDH1A1 3866/4885LMNA 226/4885HSD17B10 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.